ArticleCureus2025
Gastric Leiomyosarcoma: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric leiomyosarcoma is an exceptionally rare malignancy. This case report describes a 57-year-old woman, previously healthy, who presented to the emergency department with signs of upper gastrointestinal bleeding and severe anemia. Urgent upper endoscopy revealed a large ulcerated lesion on the greater curvature of the stomach, raising suspicion for a gastrointestinal stromal tumor (GIST). Biopsies suggested a mesenchymal neoplasm with epithelioid features. Staging imaging excluded metastatic disease. The patient underwent a laparoscopic radical subtotal gastrectomy with Roux-en-Y reconstruction. Histological and immunohistochemical analysis concluded a diagnosis of gastric leimyosarcoma. Surgical margins were negative, and no lymph node metastases were found. This case underscores the importance of immunohistochemistry in differentiating leiomyosarcoma from other mesenchymal tumors such as GIST. Despite surgical resection being the mainstay of treatment, the prognosis remains guarded due to high mitotic activity and the potential for recurrence. This report adds to the limited literature and highlights the need for further studies to establish standardized management protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.